By Alex Philippidis

NEW YORK (GenomeWeb News) – Australia's Prince of Wales Medical Research Institute (POWMRI) said it plans to start construction immediately on the A$42 million (US$38.6 million) phase — the first of four phases — of a new A$118 million building designed to enhance its research into brain injury and Alzheimer's and Parkinson's disease, following approval of the project's planning application earlier this month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.